In recent trading session, Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) saw 0.35 million shares changing hands at last check today with its beta currently measuring 3.55. Company’s recent per share price level of $0.52 trading at $0.05 or 10.40% at last check today assigns it a market valuation of $27.12M. That most recent trading price of CDIO’s stock is at a discount of -257.69% from its 52-week high price of $1.86 and is indicating a premium of 63.46% from its 52-week low price of $0.19.

Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) trade information

Upright in the green today for gaining 10.40%, in the last five days CDIO remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $0.52 price level, adding 23.52% to its value on the day. Cardio Diagnostics Holdings Inc’s shares saw a change of -43.29% in year-to-date performance and have moved -23.22% in past 5-day. Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) showed a performance of -17.05% in past 30-days.

Cardio Diagnostics Holdings Inc (CDIO) estimates and forecasts

This year revenue growth is estimated to rise 222.20% from the last financial year’s standing.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 25k for the same. And 1 analysts are in estimates of company making revenue of 50k in the next quarter. Company posted 5.31k and 15.93k of sales in current and next quarters respectively a year earlier.

On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024, the former fund manager was holding 232.14 shares of worth $0.12 million or 0.45% of the total outstanding shares. The later fund manager was in possession of 203.3 shares on Dec 31, 2024, making its stake of worth around $0.11 million in the company or a holder of 0.39% of company’s stock.